Squarepoint’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-13,174
Closed -$4.33M 2779
2024
Q4
$4.33M Sell
13,174
-8,712
-40% -$2.86M ﹤0.01% 833
2024
Q3
$7.32M Sell
21,886
-4,025
-16% -$1.35M 0.01% 593
2024
Q2
$7.08M Sell
25,911
-34,691
-57% -$9.47M 0.01% 567
2024
Q1
$21M Sell
60,602
-78,525
-56% -$27.2M 0.04% 284
2023
Q4
$44.9M Buy
139,127
+98,098
+239% +$31.7M 0.09% 131
2023
Q3
$14.7M Buy
41,029
+11,122
+37% +$3.99M 0.04% 305
2023
Q2
$11.3M Buy
+29,907
New +$11.3M 0.03% 331
2022
Q2
Sell
-24,482
Closed -$13.8M 2138
2022
Q1
$13.8M Buy
24,482
+12,413
+103% +$6.99M 0.06% 245
2021
Q4
$9.12M Buy
12,069
+9,807
+434% +$7.41M 0.02% 357
2021
Q3
$1.69M Sell
2,262
-5,255
-70% -$3.92M ﹤0.01% 860
2021
Q2
$4.84M Sell
7,517
-10,598
-59% -$6.83M 0.02% 475
2021
Q1
$10.3M Buy
18,115
+17,430
+2,545% +$9.96M 0.06% 237
2020
Q4
$399K Sell
685
-899
-57% -$524K ﹤0.01% 1658
2020
Q3
$816K Sell
1,584
-17,884
-92% -$9.21M 0.01% 1043
2020
Q2
$8.79M Buy
19,468
+6,030
+45% +$2.72M 0.14% 195
2020
Q1
$4.71M Buy
13,438
+819
+6% +$287K 0.12% 214
2019
Q4
$4.67M Sell
12,619
-44,667
-78% -$16.5M 0.03% 513
2019
Q3
$19.1M Buy
+57,286
New +$19.1M 0.17% 136
2019
Q2
Sell
-36,892
Closed -$11.3M 2301
2019
Q1
$11.3M Buy
+36,892
New +$11.3M 0.12% 205
2018
Q4
Sell
-3,166
Closed -$991K 1921
2018
Q3
$991K Sell
3,166
-8,337
-72% -$2.61M 0.01% 990
2018
Q2
$3.32M Buy
11,503
+3,088
+37% +$891K 0.04% 494
2018
Q1
$2.1M Buy
8,415
+4,614
+121% +$1.15M 0.03% 560
2017
Q4
$907K Buy
3,801
+915
+32% +$218K 0.02% 865
2017
Q3
$641K Buy
2,886
+911
+46% +$202K 0.01% 870
2017
Q2
$447K Buy
+1,975
New +$447K 0.01% 999
2016
Q2
Sell
-5,169
Closed -$707K 1106
2016
Q1
$707K Buy
5,169
+2,940
+132% +$402K 0.05% 485
2015
Q4
$309K Buy
+2,229
New +$309K 0.03% 783
2015
Q2
Sell
-4,372
Closed -$591K 466
2015
Q1
$591K Buy
+4,372
New +$591K 0.21% 160